1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Krimm, I. Gilles, N. Sautiere, P. Stankiewicz, M. Pelhate, M. Gordon, D. Lancelin, J.-M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 285 1749 1763 10.1006/jmbi.1998.2418 9917409 NMR structures and activity of a novel alpha-like toxin from the scorpion Leiurus quinquestriatus hebraeus. 1999 UK Toxicon TOXIA6 2043 0041-0101 36 1141 New Toxins Acting on Sodium Channels from the Scorpion Leiurus Quinquestriatus Hebraeus Suggest a Clue to Mammalian Vs Insect Selectivity 1998 Amsterdam : Harwood Academic Publishers NE Toxins and Signal Transduction (in: Cellular and Molecular Mechanisms of Toxin Action, V.1) BOOKA7 2207 90-5702-078-5 119 Sodium Channels as Targets for Neurotoxins. Modes of Action and Interaction of Neurotoxins with Receptor Sites on Sodium Channels 1997 1 2 10.2210/pdb1bmr/pdb pdb_00001bmr 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 AMIDATED AT THE C-TERMINAL POSITION (CONH2) . THIS STRUCTURE IS IN EQUILIBRIUM WITH THE PRO9-GLU10 CIS ISOMER (PDB:1FH3). 7063.992 LQH III ALPHA-LIKE TOXIN 1 nat polymer no yes VRDGYIAQPENCVYHCFPGSSGCDTLCKEKGGTSGHCGFKVGHGLACWCNALPDNVGIIVEGEKCHS(NH2) VRDGYIAQPENCVYHCFPGSSGCDTLCKEKGGTSGHCGFKVGHGLACWCNALPDNVGIIVEGEKCHSX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Leiurus sample 6884 VENOMOUS APPARATUS Leiurus quinquestriatus hebraeus VENOM Leiurus quinquestriatus hebraeus database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1999-02-16 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1998-07-24 REL REL THE STRUCTURE WAS DETERMINED USING TWO-DIMENSIONAL NMR ON A NATURAL UNLABELLED SAMPLE OF LQH III ALPHA LIKE TOXIN FROM THE SCORPION LEIURUS QUINQUESTRIATUS HEBRAEUS VENOM. LEAST RESTRAINT VIOLATION 60 25 DQF-COSY TOCSY/HOHAHA NOESY 100 mM PHOSPHATE BUFFER 5.8 1 atm 311 K HYBRID DISTANCE GEOMETRY/ SIMULATED ANNEALING 90% WATER/10% D2O BRUNGER refinement X-PLOR 3.851 structure solution Gifa 4.2 structure solution BRUKER XWINNMR XWINNMR structure solution X-PLOR 3.851 500 Bruker AVANCE DRX500 VAL 1 n 1 VAL 1 A ARG 2 n 2 ARG 2 A ASP 3 n 3 ASP 3 A GLY 4 n 4 GLY 4 A TYR 5 n 5 TYR 5 A ILE 6 n 6 ILE 6 A ALA 7 n 7 ALA 7 A GLN 8 n 8 GLN 8 A PRO 9 n 9 PRO 9 A GLU 10 n 10 GLU 10 A ASN 11 n 11 ASN 11 A CYS 12 n 12 CYS 12 A VAL 13 n 13 VAL 13 A TYR 14 n 14 TYR 14 A HIS 15 n 15 HIS 15 A CYS 16 n 16 CYS 16 A PHE 17 n 17 PHE 17 A PRO 18 n 18 PRO 18 A GLY 19 n 19 GLY 19 A SER 20 n 20 SER 20 A SER 21 n 21 SER 21 A GLY 22 n 22 GLY 22 A CYS 23 n 23 CYS 23 A ASP 24 n 24 ASP 24 A THR 25 n 25 THR 25 A LEU 26 n 26 LEU 26 A CYS 27 n 27 CYS 27 A LYS 28 n 28 LYS 28 A GLU 29 n 29 GLU 29 A LYS 30 n 30 LYS 30 A GLY 31 n 31 GLY 31 A GLY 32 n 32 GLY 32 A THR 33 n 33 THR 33 A SER 34 n 34 SER 34 A GLY 35 n 35 GLY 35 A HIS 36 n 36 HIS 36 A CYS 37 n 37 CYS 37 A GLY 38 n 38 GLY 38 A PHE 39 n 39 PHE 39 A LYS 40 n 40 LYS 40 A VAL 41 n 41 VAL 41 A GLY 42 n 42 GLY 42 A HIS 43 n 43 HIS 43 A GLY 44 n 44 GLY 44 A LEU 45 n 45 LEU 45 A ALA 46 n 46 ALA 46 A CYS 47 n 47 CYS 47 A TRP 48 n 48 TRP 48 A CYS 49 n 49 CYS 49 A ASN 50 n 50 ASN 50 A ALA 51 n 51 ALA 51 A LEU 52 n 52 LEU 52 A PRO 53 n 53 PRO 53 A ASP 54 n 54 ASP 54 A ASN 55 n 55 ASN 55 A VAL 56 n 56 VAL 56 A GLY 57 n 57 GLY 57 A ILE 58 n 58 ILE 58 A ILE 59 n 59 ILE 59 A VAL 60 n 60 VAL 60 A GLU 61 n 61 GLU 61 A GLY 62 n 62 GLY 62 A GLU 63 n 63 GLU 63 A LYS 64 n 64 LYS 64 A CYS 65 n 65 CYS 65 A HIS 66 n 66 HIS 66 A SER 67 n 67 SER 67 A NH2 68 n 68 NH2 68 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O SER 34 A O SER 34 A N ASN 50 A N ASN 50 A O CYS 47 A O CYS 47 A N ILE 6 A N ILE 6 3 A A OE1 HG GLN SER 8 67 1.57 8 A A O HG1 SER THR 21 25 1.59 12 A A O HG1 SER THR 21 25 1.58 1 A A GLN PRO 8 9 -143.16 1 A A SER SER 20 21 -145.30 3 A A GLN PRO 8 9 -145.17 3 A A ALA LEU 51 52 149.17 5 A A GLN PRO 8 9 -141.29 6 A A GLN PRO 8 9 -135.21 9 A A GLN PRO 8 9 -142.58 9 A A GLY SER 19 20 -147.09 10 A A GLN PRO 8 9 -135.72 10 A A LYS VAL 40 41 149.86 11 A A GLN PRO 8 9 -149.60 15 A A GLN PRO 8 9 -149.55 21 A A GLN PRO 8 9 -141.25 23 A A GLN PRO 8 9 -145.44 24 A A GLN PRO 8 9 -136.29 1 A TYR 5 0.079 SIDE CHAIN 2 A TYR 5 0.073 SIDE CHAIN 6 A TYR 5 0.087 SIDE CHAIN 7 A TYR 5 0.083 SIDE CHAIN 8 A TYR 5 0.107 SIDE CHAIN 10 A TYR 5 0.080 SIDE CHAIN 11 A TYR 5 0.073 SIDE CHAIN 13 A TYR 14 0.079 SIDE CHAIN 14 A TYR 5 0.104 SIDE CHAIN 16 A TYR 5 0.082 SIDE CHAIN 24 A TYR 5 0.075 SIDE CHAIN 1 -16.34 2.70 111.00 94.66 A A A N CA C GLN GLN GLN 8 8 8 N 1 -15.50 2.50 113.10 97.60 A A A N CA C GLY GLY GLY 19 19 19 N 1 -15.61 2.50 113.10 97.49 A A A N CA C GLY GLY GLY 35 35 35 N 1 -16.49 2.70 111.00 94.51 A A A N CA C VAL VAL VAL 60 60 60 N 2 -18.23 2.70 111.00 92.77 A A A N CA C ASP ASP ASP 3 3 3 N 2 -15.13 2.50 113.10 97.97 A A A N CA C GLY GLY GLY 19 19 19 N 2 9.21 1.50 110.50 119.71 A A A N CA CB SER SER SER 20 20 20 N 2 -15.55 2.50 113.10 97.55 A A A N CA C GLY GLY GLY 57 57 57 N 3 -16.63 2.70 111.00 94.37 A A A N CA C ASP ASP ASP 3 3 3 N 3 -17.36 2.70 111.00 93.64 A A A N CA C ASN ASN ASN 11 11 11 N 3 -15.87 2.50 113.10 97.23 A A A N CA C GLY GLY GLY 19 19 19 N 3 -17.20 2.50 113.10 95.90 A A A N CA C GLY GLY GLY 38 38 38 N 3 9.51 1.40 110.10 119.61 A A A N CA CB ALA ALA ALA 51 51 51 N 4 -16.40 2.50 113.10 96.70 A A A N CA C GLY GLY GLY 19 19 19 N 4 -15.01 2.50 113.10 98.09 A A A N CA C GLY GLY GLY 38 38 38 N 4 -16.43 2.50 113.10 96.67 A A A N CA C GLY GLY GLY 57 57 57 N 5 -17.07 2.70 111.00 93.93 A A A N CA C ASN ASN ASN 11 11 11 N 5 -16.80 2.70 111.00 94.20 A A A N CA C HIS HIS HIS 15 15 15 N 5 -15.84 2.50 113.10 97.26 A A A N CA C GLY GLY GLY 57 57 57 N 6 -16.87 2.70 111.00 94.13 A A A N CA C PHE PHE PHE 39 39 39 N 7 -17.44 2.70 111.00 93.56 A A A N CA C TYR TYR TYR 14 14 14 N 7 -15.28 2.50 113.10 97.82 A A A N CA C GLY GLY GLY 19 19 19 N 7 -18.28 2.50 113.10 94.82 A A A N CA C GLY GLY GLY 62 62 62 N 7 -16.28 2.70 111.00 94.72 A A A N CA C CYS CYS CYS 65 65 65 N 8 -18.38 2.70 111.00 92.62 A A A N CA C ASN ASN ASN 11 11 11 N 8 -16.94 2.70 111.00 94.06 A A A N CA C CYS CYS CYS 16 16 16 N 8 -15.17 2.50 113.10 97.93 A A A N CA C GLY GLY GLY 19 19 19 N 9 -16.30 2.50 113.10 96.80 A A A N CA C GLY GLY GLY 38 38 38 N 9 -15.85 2.50 113.10 97.25 A A A N CA C GLY GLY GLY 57 57 57 N 10 -16.44 2.70 111.00 94.56 A A A N CA C ASP ASP ASP 3 3 3 N 10 -17.15 2.70 111.00 93.85 A A A N CA C GLN GLN GLN 8 8 8 N 10 -18.62 2.70 111.00 92.38 A A A N CA C ASN ASN ASN 11 11 11 N 10 -17.36 2.70 111.00 93.64 A A A N CA C LYS LYS LYS 40 40 40 N 10 -16.22 2.70 111.00 94.78 A A A N CA C LEU LEU LEU 45 45 45 N 10 -17.40 2.70 111.00 93.60 A A A N CA C CYS CYS CYS 65 65 65 N 11 -17.66 2.70 111.00 93.34 A A A N CA C TYR TYR TYR 14 14 14 N 11 -16.60 2.70 111.00 94.40 A A A N CA C CYS CYS CYS 16 16 16 N 11 -16.31 2.70 111.00 94.69 A A A N CA C PHE PHE PHE 17 17 17 N 11 -16.93 2.50 113.10 96.17 A A A N CA C GLY GLY GLY 19 19 19 N 12 -17.75 2.50 113.10 95.35 A A A N CA C GLY GLY GLY 19 19 19 N 12 -16.07 2.50 113.10 97.03 A A A N CA C GLY GLY GLY 57 57 57 N 13 -16.99 2.70 111.00 94.01 A A A N CA C ASP ASP ASP 3 3 3 N 13 -16.68 2.70 111.00 94.32 A A A N CA C ALA ALA ALA 51 51 51 N 14 -16.61 2.70 111.00 94.39 A A A N CA C ASP ASP ASP 3 3 3 N 14 9.08 1.50 110.80 119.88 A A A N CA CB CYS CYS CYS 12 12 12 N 15 -15.38 2.50 113.10 97.72 A A A N CA C GLY GLY GLY 42 42 42 N 15 -17.30 2.50 113.10 95.80 A A A N CA C GLY GLY GLY 44 44 44 N 16 -16.61 2.70 111.00 94.39 A A A N CA C ASP ASP ASP 3 3 3 N 16 -18.31 2.70 111.00 92.69 A A A N CA C TYR TYR TYR 14 14 14 N 16 -15.03 2.50 113.10 98.07 A A A N CA C GLY GLY GLY 19 19 19 N 16 -15.32 2.50 113.10 97.78 A A A N CA C GLY GLY GLY 35 35 35 N 16 -16.90 2.50 113.10 96.20 A A A N CA C GLY GLY GLY 38 38 38 N 17 -16.67 2.70 111.00 94.33 A A A N CA C ASP ASP ASP 3 3 3 N 17 -18.32 2.70 111.00 92.68 A A A N CA C TYR TYR TYR 14 14 14 N 17 -16.61 2.70 111.00 94.39 A A A N CA C VAL VAL VAL 41 41 41 N 19 -19.58 2.70 111.00 91.42 A A A N CA C TYR TYR TYR 14 14 14 N 19 -16.91 2.70 111.00 94.09 A A A N CA C CYS CYS CYS 16 16 16 N 19 -17.21 2.50 113.10 95.89 A A A N CA C GLY GLY GLY 19 19 19 N 19 -16.11 2.50 113.10 96.99 A A A N CA C GLY GLY GLY 57 57 57 N 20 -16.74 2.70 111.00 94.26 A A A N CA C ASP ASP ASP 3 3 3 N 20 9.88 1.50 110.50 120.38 A A A N CA CB SER SER SER 20 20 20 N 20 -17.43 2.70 111.00 93.57 A A A N CA C ALA ALA ALA 51 51 51 N 21 -17.13 2.70 111.00 93.87 A A A N CA C ASP ASP ASP 3 3 3 N 21 -17.53 2.70 111.00 93.47 A A A N CA C GLN GLN GLN 8 8 8 N 21 -18.54 2.70 111.00 92.46 A A A N CA C ASN ASN ASN 11 11 11 N 21 -18.10 2.70 111.00 92.90 A A A N CA C CYS CYS CYS 65 65 65 N 22 -17.54 2.70 111.00 93.46 A A A N CA C ASP ASP ASP 3 3 3 N 22 -17.33 2.70 111.00 93.67 A A A N CA C CYS CYS CYS 16 16 16 N 23 -17.43 2.70 111.00 93.57 A A A N CA C GLN GLN GLN 8 8 8 N 23 -19.42 2.70 111.00 91.58 A A A N CA C ASN ASN ASN 11 11 11 N 23 -16.81 2.70 111.00 94.19 A A A N CA C CYS CYS CYS 16 16 16 N 23 -17.60 2.70 111.00 93.40 A A A N CA C VAL VAL VAL 60 60 60 N 24 -17.25 2.70 111.00 93.75 A A A N CA C ASP ASP ASP 3 3 3 N 24 -19.45 2.50 113.10 93.65 A A A N CA C GLY GLY GLY 62 62 62 N 25 -17.65 2.70 111.00 93.35 A A A N CA C ASP ASP ASP 3 3 3 N 25 -17.48 2.70 111.00 93.52 A A A N CA C ASN ASN ASN 11 11 11 N 25 -15.98 2.50 113.10 97.12 A A A N CA C GLY GLY GLY 44 44 44 N 25 -17.38 2.70 111.00 93.62 A A A N CA C ALA ALA ALA 51 51 51 N 25 -16.55 2.70 111.00 94.45 A A A N CA C CYS CYS CYS 65 65 65 N 1 A ALA 7 -134.87 -150.98 1 A GLU 10 -86.37 46.85 1 A CYS 12 -122.38 -162.64 1 A PRO 18 -56.34 96.47 1 A HIS 43 -108.94 -69.85 1 A ALA 51 73.90 49.73 1 A ILE 58 -146.21 -144.25 1 A GLU 63 -102.32 -144.80 2 A ALA 7 -144.09 -159.19 2 A ASN 11 73.24 37.40 2 A CYS 12 -108.94 -162.33 2 A SER 20 122.80 -34.91 2 A HIS 36 -177.76 -154.51 2 A HIS 43 -114.97 -71.67 2 A ALA 51 65.01 72.58 2 A ILE 58 -152.32 -140.64 2 A GLU 61 62.41 -54.80 3 A ALA 7 -94.30 -144.76 3 A GLU 10 -88.40 -76.35 3 A ASN 11 -176.84 144.02 3 A CYS 12 160.69 -153.48 3 A TYR 14 -86.01 -148.89 3 A PRO 18 -53.03 103.82 3 A HIS 36 -156.66 -153.04 3 A HIS 43 -125.10 -64.71 3 A ALA 51 90.06 135.40 3 A ILE 58 -117.97 -153.81 3 A GLU 63 -168.89 -169.40 4 A ALA 7 -135.77 -128.61 4 A PRO 9 -74.89 35.14 4 A CYS 12 -116.89 -160.26 4 A TYR 14 -96.62 -154.27 4 A PRO 18 -51.43 98.69 4 A SER 21 -39.59 -71.48 4 A HIS 36 -155.86 -157.43 4 A ALA 51 77.02 54.94 4 A ILE 58 -139.66 -126.65 4 A GLU 61 150.31 -166.22 4 A GLU 63 69.54 -47.44 5 A ALA 7 -109.59 -149.94 5 A PRO 9 -75.58 29.81 5 A GLU 10 -120.35 -78.74 5 A CYS 12 173.42 -157.09 5 A CYS 16 -160.45 -151.01 5 A HIS 43 -117.48 -73.88 5 A ALA 51 77.36 47.67 5 A ILE 58 -146.81 -156.46 5 A GLU 61 64.08 -110.51 5 A GLU 63 -101.18 -71.40 6 A ALA 7 -111.16 -161.44 6 A ASN 11 171.10 142.53 6 A CYS 12 171.31 -157.20 6 A VAL 41 50.01 -138.24 6 A HIS 43 -98.79 -64.41 6 A ALA 51 76.37 73.59 6 A ILE 58 -136.14 -152.96 6 A GLU 63 -106.31 -138.36 6 A LYS 64 -166.14 -163.04 6 A HIS 66 -145.48 25.03 7 A ASN 11 66.25 61.54 7 A CYS 12 -122.13 -137.58 7 A SER 20 -84.09 46.34 7 A VAL 41 -41.64 -71.59 7 A HIS 43 -167.59 -60.52 7 A ALA 51 71.16 49.76 7 A ILE 58 -139.18 -147.46 7 A GLU 61 173.71 -167.05 7 A GLU 63 -163.72 -61.53 8 A GLU 10 -118.13 -83.28 8 A CYS 12 176.30 -157.11 8 A PRO 18 -63.53 94.94 8 A HIS 43 -106.69 -74.93 8 A GLU 63 -123.44 -149.82 8 A LYS 64 -167.09 -161.94 9 A ASN 11 77.28 44.89 9 A PRO 18 -68.65 67.67 9 A SER 20 -86.25 45.02 9 A HIS 36 -177.91 -152.50 9 A LYS 40 -168.72 57.35 9 A HIS 43 -175.01 -154.63 9 A ALA 51 63.33 74.10 9 A ILE 58 -153.77 -147.65 9 A GLU 63 -149.24 -87.07 9 A LYS 64 -162.61 -167.13 9 A HIS 66 -116.25 -152.22 10 A ALA 7 -96.68 -150.92 10 A PRO 9 -83.00 30.81 10 A GLU 10 -106.25 -89.45 10 A CYS 12 176.59 -163.54 10 A PRO 18 -75.05 49.67 10 A LYS 40 -154.21 -141.86 10 A GLU 61 64.80 -117.25 11 A ASN 11 82.06 48.19 11 A HIS 15 -92.83 -156.65 11 A PRO 18 -62.45 99.33 11 A HIS 43 -128.77 -78.83 11 A ALA 51 57.86 71.26 11 A ILE 58 -144.10 -134.59 11 A GLU 61 67.85 -70.30 11 A GLU 63 -31.20 -83.24 11 A LYS 64 -169.26 -167.65 12 A PRO 9 -70.57 32.47 12 A CYS 12 -110.93 -154.72 12 A PRO 18 -62.96 67.97 12 A HIS 36 -174.10 -178.86 12 A HIS 43 -121.07 -74.41 12 A ALA 51 66.66 66.12 12 A ILE 58 -142.31 -141.70 12 A GLU 61 -170.68 -173.40 12 A GLU 63 -105.49 -71.48 12 A HIS 66 -113.42 62.45 13 A ALA 7 -126.26 -148.42 13 A PRO 9 -82.01 39.90 13 A ASN 11 64.56 60.23 13 A CYS 12 -117.90 -158.37 13 A SER 20 91.24 12.04 13 A LYS 40 -155.42 47.96 13 A VAL 41 61.68 -147.96 13 A HIS 43 -150.26 -69.57 13 A ILE 58 -125.34 -134.65 13 A GLU 63 -104.91 -84.91 13 A HIS 66 -102.53 74.33 14 A ASN 11 86.73 126.62 14 A CYS 12 156.90 126.47 14 A HIS 36 -156.76 -159.18 14 A HIS 43 -125.56 -68.89 14 A ALA 51 77.70 41.89 14 A ILE 58 -148.25 -143.74 14 A GLU 61 80.39 -115.82 14 A LYS 64 -173.56 -177.20 15 A GLU 10 -84.67 38.70 15 A CYS 12 -104.15 -146.68 15 A LYS 40 -157.74 58.22 15 A VAL 41 69.77 -172.80 15 A HIS 43 -130.37 -39.16 15 A GLU 63 178.48 -178.86 15 A LYS 64 -127.09 -154.64 16 A ASN 11 83.23 43.44 16 A PRO 18 -55.88 96.60 16 A HIS 43 -106.19 -66.85 16 A ALA 51 64.62 61.89 16 A ILE 58 -152.82 -154.63 16 A GLU 61 75.92 -56.54 16 A GLU 63 -105.36 -165.32 16 A LYS 64 -109.97 -149.90 17 A ASN 11 75.32 41.34 17 A CYS 12 -117.05 -154.86 17 A SER 20 107.30 -6.10 17 A HIS 36 177.95 -160.07 17 A HIS 43 -90.24 -90.61 17 A ILE 58 -139.09 -151.80 17 A GLU 61 60.37 -64.42 17 A GLU 63 -102.82 -90.09 18 A PRO 9 -68.96 0.34 18 A ASN 11 73.34 57.54 18 A SER 20 95.84 21.84 18 A HIS 43 -139.69 -79.56 18 A ILE 58 -147.28 -151.22 18 A GLU 61 71.67 -57.86 18 A LYS 64 -179.71 -173.06 19 A ASN 11 74.43 54.64 19 A HIS 15 -88.50 -150.57 19 A HIS 43 -127.98 -81.11 19 A ILE 58 -156.68 -155.85 19 A GLU 63 178.59 -154.03 19 A LYS 64 -168.76 -156.69 20 A GLU 10 -95.28 45.35 20 A CYS 12 -128.29 -160.59 20 A SER 20 134.11 -42.92 20 A HIS 36 -171.97 -172.99 20 A LYS 40 -156.83 82.37 20 A HIS 43 -116.22 -75.34 20 A VAL 60 -118.36 -92.82 20 A GLU 61 77.80 59.27 20 A GLU 63 179.92 -158.08 21 A ALA 7 -100.97 -144.81 21 A GLU 10 -104.38 -78.52 21 A CYS 12 176.29 -166.68 21 A SER 20 82.56 23.85 21 A PHE 39 -168.89 -169.33 21 A LYS 40 97.65 61.29 21 A HIS 43 -172.09 -132.21 21 A GLU 61 65.59 -114.58 22 A ASN 11 76.18 52.65 22 A PRO 18 -66.70 44.58 22 A SER 20 -78.25 38.12 22 A HIS 43 -97.31 -75.86 22 A ALA 51 73.08 57.84 22 A ILE 58 -140.83 -149.68 22 A GLU 63 -98.99 -159.18 23 A ALA 7 -97.39 -147.11 23 A GLU 10 -95.48 -82.00 23 A CYS 12 -174.59 -166.14 23 A TYR 14 -88.83 -159.01 23 A CYS 16 -161.23 -153.63 23 A PRO 18 -67.82 44.06 23 A LYS 40 128.11 63.66 23 A HIS 43 -158.33 -107.43 23 A GLU 63 -97.04 -106.42 23 A LYS 64 174.07 -140.63 24 A ALA 7 -100.24 -158.38 24 A PRO 9 -78.49 26.47 24 A GLU 10 -115.50 -78.95 24 A CYS 12 164.91 -152.73 24 A TYR 14 -87.80 -158.87 24 A SER 20 85.23 11.85 24 A ALA 46 -136.59 -158.28 24 A ALA 51 65.64 78.65 24 A ILE 58 -129.83 -146.57 24 A GLU 61 -179.22 -62.75 25 A ALA 7 -116.41 -158.55 25 A PRO 9 -78.36 27.16 25 A GLU 10 -111.37 -82.07 25 A CYS 12 170.66 -156.21 25 A THR 33 -85.78 -76.29 25 A LYS 40 -148.11 50.39 25 A VAL 41 60.61 -142.39 25 A HIS 43 -159.93 -47.90 25 A ALA 51 -171.00 144.52 25 A ILE 58 -144.89 -156.99 25 A GLU 61 60.47 -120.21 model building X-PLOR 3.851 refinement X-PLOR 3.851 phasing X-PLOR 3.851 ALPHA-LIKE TOXIN LQH III FROM SCORPION LEIURUS QUINQUESTRIATUS HEBRAEUS, NMR, 25 STRUCTURES 1 Y N A SER 21 A SER 21 HELX_P A LYS 30 A LYS 30 1 1 10 disulf 2.034 A CYS 12 A SG CYS 12 1_555 A CYS 65 A SG CYS 65 1_555 disulf 2.017 A CYS 16 A SG CYS 16 1_555 A CYS 37 A SG CYS 37 1_555 disulf 2.012 A CYS 23 A SG CYS 23 1_555 A CYS 47 A SG CYS 47 1_555 disulf 2.018 A CYS 27 A SG CYS 27 1_555 A CYS 49 A SG CYS 49 1_555 covale 1.357 both A SER 67 A C SER 67 1_555 A NH2 68 A N NH2 68 1_555 TOXIN ALPHA-LIKE TOXIN, SCORPION TOXIN, SODIUM CHANNEL INHIBITOR, TOXIN SCL3_LEIQH UNP 1 1 P56678 VRDGYIAQPENCVYHCFPGSSGCDTLCKEKGGTSGHCGFKVGHGLACWCNALPDNVGIIVEGEKCHS 1 67 1BMR 1 67 P56678 A 1 1 67 3 anti-parallel anti-parallel A SER 34 A SER 34 A LYS 40 A LYS 40 A GLY 44 A GLY 44 A LEU 52 A LEU 52 A ARG 2 A ARG 2 A ILE 6 A ILE 6 BINDING SITE FOR RESIDUE NH2 A 68 A NH2 68 Software 1 A SER 67 A SER 67 1 1_555 1 P 1